Autism Spectrum Disorder and Medical Cannabis: Research
Medical cannabis for autism spectrum disorder has been tested mostly as CBD oil taken by mouth, in children and teens who need a lot of support with behavior. The trials are small and the results are mixed: a 2025 systematic review of 11 randomized trials judged the evidence inconclusive [1]. Smoking and vaping were not part of these studies, and whether any cannabinoid makes sense for you or your child is a decision for a physician who sees the full medicine list.
Built on peer-reviewed research published from 2011 to 2026: randomized trials, systematic reviews, observational studies and laboratory work
When irritability, sleep and anxiety stay hard despite therapy
Most families who look up cannabis and autism are not looking for a cure. They are looking for a way through the parts of the day that therapy has not reached yet: the meltdown that ends with a bruise, the night that starts at 3 a.m., the dread before every trip to the store.
Irritability, aggression and self-injury
Some autistic children and adults hit, bite, throw things or hurt themselves when they are overwhelmed or cannot say what is wrong. Behavioral therapy helps many of them, slowly. When it does not help enough, doctors often add risperidone or aripiprazole, the two medicines the FDA has approved for irritability linked to autism [2]. They work for many children, and they also bring weight gain, sedation, dizziness and nausea, which is why families ask what else exists [3].
Sleep that never settles
Trouble falling asleep, waking for hours at night and starting the day before dawn are common in autism. A child who does not sleep has a harder day, and so does everyone who looks after them. Sleep problems show up in cannabinoid trials too — as a side effect to watch, not only as a target [3].
Anxiety and sensory overload
Noise, light, crowds, a changed routine: what is background for most people can feel like an alarm that does not switch off. Anxiety is one of the most frequent conditions that come alongside autism, in children and in adults, and it often drives the behavior that looks like defiance from the outside.
Underneath all three sits a tired household. Parents describe years of rearranging life around rituals and triggers — researchers even have a name for it, family accommodation, and one open-label study measured whether it changed with cannabis treatment [4]. Many parents also notice CBD for sale online, at gas stations and at markets, with labels promising calm. Those products are not lab-checked the way regulated medical products are, and the dose and the THC inside can differ from what is printed.
What is autism spectrum disorder?
Autism spectrum disorder is a lifelong neurodevelopmental condition: a difference in how the brain develops that shapes how a person communicates, relates to others, and responds to routine and to the senses. Doctors diagnose it by the two groups of signs set out in the DSM-5, the diagnostic manual of the American Psychiatric Association — differences in social communication, and restricted or repetitive patterns of behavior, interests or activities [5]. Signs begin in early childhood, even when they are only recognized years later [6].
“Spectrum” is meant literally. One autistic person speaks fluently, works and lives alone; another uses few or no words and needs help with every part of the day. Many have another diagnosis too — ADHD and hyperactivity, anxiety, epilepsy, sleep problems, intellectual disability or digestive trouble are all common companions [2]. Autism is common and is tracked in the United States by the CDC’s monitoring network [7]; it is not a rare condition and not one that people grow out of.
Social communication
What it looks like: difficulty with back-and-forth conversation, reading facial expressions and tone, and making or keeping friendships [5].
In children: delayed speech or lost words, little pointing or shared attention, playing alongside rather than with others.
In adults: exhaustion after social time, taking words literally, rehearsing conversations to get them “right.”
Restricted and repetitive behavior
What it looks like: repeated movements or phrases, a strong need for sameness, intense focused interests, and over- or under-reaction to sound, touch, light or pain [5].
In children: lining up toys, distress at a changed route, covering ears, hand-flapping when excited.
In adults: rigid routines that bring calm, deep expertise in one subject, black-and-white thinking, avoiding noisy places.
Quick answers
What causes autism? Is it hereditary?
There is no single cause. Genes play the largest known part: autism runs in families, and studies of twins and siblings show that inherited differences explain much of the risk, with many genes each adding a little [2]. Factors before birth add to that — older parents, very premature birth, some pregnancy complications and certain medicines taken in pregnancy have been linked to a higher chance [2].
Autism is not caught from someone, and it is not caused by parenting. It is present from early development; what changes over time is how visible it is and how much support a person needs.
Genetic testing is often offered after a diagnosis. It can find a known genetic condition in some children, which may matter for other health checks and for family planning, but a normal result does not rule autism out [9].
Does cannabis use in pregnancy cause autism?
The large studies so far do not show that it does — and they cannot prove that it does not. A multi-cohort study in the U.S. ECHO program found no clear link between cannabis exposure before birth and an autism diagnosis (odds ratio 0.93, 95% CI 0.55 to 1.60) [10], and the SEED case-control study also found no association with use around pregnancy [11]. Both are observational: they show links, not cause.
That is not permission. THC reaches the developing baby, and the safety of cannabis in pregnancy and breastfeeding is not established. Anyone pregnant or planning a pregnancy should talk to their obstetrician before using any cannabis product.
How is autism diagnosed? DSM-5 criteria and the ICD-10 code
There is no blood test or scan for autism. A developmental pediatrician, child neurologist, psychiatrist or psychologist makes the diagnosis by watching the person, talking with them and their family, and using structured tools. Pediatricians screen all toddlers with a short questionnaire, the M-CHAT, at the 18- and 24-month checkups and refer for a full evaluation when it flags a concern [9].
The DSM-5 lists five criteria, all of which must be met [5][6]:
- A. Social communication and interaction. Lasting differences in all three areas: back-and-forth social and emotional exchange, nonverbal communication such as eye contact and gestures, and developing and understanding relationships.
- B. Restricted, repetitive behavior. At least two of four: repeated movements, speech or use of objects; insistence on sameness and routine; intense, narrow interests; unusual reactions to sensory input.
- C. Early onset. Signs are present in early childhood, though they may only become obvious when social demands grow, or may be hidden by learned strategies later in life.
- D. Real impact. The signs cause clinically significant difficulty in social, school, work or other everyday areas.
- E. Not better explained by something else. Intellectual disability or global developmental delay alone do not account for them.
Records use a code from the ICD-10-CM, the classification used for billing and medical records in the United States. Autism spectrum disorder is coded F84.0, at any level of support [12]. The “F” is the chapter letter for mental, behavioral and neurodevelopmental conditions, which is why people search for the autism “F code.” The newer international version, ICD-11, uses 6A02 [13]. A record that names the diagnosis and who made it is what a state medical cannabis program and the certifying physician will ask to see.
Can adults be diagnosed with autism?
Yes. Autism can be diagnosed at any age, and many people are first diagnosed as teenagers or adults [2] — often after years of being treated for anxiety or depression alone. The DSM-5 criteria are the same at every age; the evaluation leans more on the person’s own account and on childhood history. More on this in autism in adults.
How many levels of autism are there? Level 1, 2 and 3
The DSM-5 describes three levels, named for how much support a person needs: Level 1, “requiring support”; Level 2, “requiring substantial support”; and Level 3, “requiring very substantial support” [5]. A clinician rates social communication and repetitive behavior separately, so a person can be Level 1 in one area and Level 2 in the other. Levels describe the present, not a fixed future: support needs often shift with age, skills, stress and the setting.
What do you want to compare?
Pick one area to read it across the levels; nothing here assigns a level.
| Level | Social communication | Repetitive behavior | Daily support |
|---|---|---|---|
| Level 1: requiring support | Speaks in full sentences but struggles with back-and-forth conversation; starting or keeping friendships is hard without support. | Inflexibility gets in the way in one or more settings; switching tasks, planning and organizing are difficult. | Often studies, works and lives with a good deal of independence; help with planning, change and social settings makes a real difference. |
| Level 2: requiring substantial support | Marked differences in spoken and nonverbal communication, visible even with support; may use simple sentences and talk mostly about narrow interests. | Repetitive behavior and difficulty with change are obvious to a casual observer; changing focus causes clear distress. | Needs regular, hands-on support at school, at work and at home. studied in cannabinoid research |
| Level 3: requiring very substantial support | Severe differences in communication; may use few words and rarely start an interaction. | Extreme difficulty coping with change; repetitive behavior affects every part of the day and interrupting it causes great distress. | Needs help with most daily activities, often around the clock. studied in cannabinoid research |
The recent trials enrolled children and teens with higher support needs, many with severe problem behaviors [14][15]. Their results say little about a Level 1 adult who struggles mainly with anxiety or sleep — a different question with even less research behind it.
Autism vs ADHD vs FASD: how they differ
Autism, ADHD and fetal alcohol spectrum disorders (FASD) can look alike in a busy classroom: trouble sitting still, missed social cues, big reactions. They are different conditions with different causes. Autism and ADHD often occur together — the DSM-5 allows both diagnoses in the same person — and hyperactivity in an autistic child may be ADHD, anxiety or sensory overload [5][16]. FASD is caused by alcohol exposure before birth, and its attention and behavior problems overlap with both [17].
Which pair do you want to compare?
Pick one; autism stays in view as the reference.
| Question | Autism | ADHD | FASD |
|---|---|---|---|
| What causes it | Mostly genetic, with some influences before birth [2]. | Strongly genetic; differences in brain development [16]. | Alcohol exposure before birth; fully preventable [17]. |
| Core signs | Social communication differences plus restricted, repetitive behavior and sensory differences. | Inattention, hyperactivity and impulsivity. | Learning, memory, attention and behavior problems; in some, smaller growth and typical facial features. |
| How it is diagnosed | DSM-5 criteria A–E, by a developmental specialist [5]. | DSM-5 ADHD criteria; symptoms in two or more settings, starting before age 12 [16]. | No single test; history of alcohol in pregnancy plus physical and developmental findings [17]. |
| Hyperactivity | Common, but not part of the definition; may come from anxiety, sensory overload or co-occurring ADHD. | A core feature in the hyperactive and combined types. | Common, along with trouble with attention and impulse control [17]. |
| Where cannabis research stands | Small trials, mostly CBD-rich oils in children with high support needs; inconclusive overall [1]. | A separate question with its own studies; see the article linked below. | No cannabinoid studies in FASD are cited on this page. |
Getting the diagnosis right matters for treatment and for paperwork: a state medical cannabis program goes by the condition in the records, and ADHD, autism and FASD are listed — or left off — separately.
Cannabis and ADHD: what the evidence says · All qualifying conditions
Autism in adults: late diagnosis and masking
Autism does not end at 18, and it does not always announce itself in childhood. Many autistic adults reach a diagnosis after a child of theirs is diagnosed, after a burnout that will not lift, or after reading someone else’s story and recognizing their own. A late diagnosis often brings relief: years of “trying harder” finally have an explanation.
Masking (camouflaging)
What it is: consciously or automatically hiding autistic traits — forcing eye contact, copying other people’s gestures, scripting small talk, holding in the urge to stim.
Why it matters: it can keep a job or a friendship going, and it is exhausting. Masking is one reason autism is missed, which the DSM-5 recognizes when it says signs may be hidden by learned strategies [5].
What helps: places and people where masking is not needed, and a clinician who asks about it directly.
Autistic burnout
What it is: a period of deep exhaustion, lost skills and lower tolerance for noise and change, usually after a long stretch of masking or overload.
How it feels: tasks that were manageable become impossible; speech may come harder; sleep and mood fall apart.
What helps: rest, fewer demands and support for the conditions that often come with it — anxiety, depression and insomnia.
How do adults get an autism diagnosis?
Start with a primary care physician or a psychiatrist, who can refer to a psychologist or psychiatrist experienced with adult autism. The evaluation uses the same DSM-5 criteria as for children [5]: interviews, questionnaires, often a talk with a parent or partner about childhood, and a look at other explanations such as social anxiety or ADHD. Bring school reports or old notes if you have them; they help show that the signs were there early.
Anxiety, depression and insomnia alongside autism
Autistic adults are more likely than others to live with anxiety, depression and sleep problems [2]. For a medical card, these matter in their own right: several of them appear on state lists of qualifying conditions more often than autism does. Each has its own evidence page — anxiety and medical cannabis, depression and medical cannabis and insomnia and medical cannabis. THC can raise anxiety in some people, so the choice between THC and CBD matters here.
Applying for a medical card as an autistic adult
An adult applies for themselves: no parent or guardian is needed unless a court has appointed one. Have the diagnosis record ready, along with the other diagnoses in your file and every medicine you take. The steps are in how to get a medical marijuana card for autism. If phone calls are hard, the whole process is written and online.
How is autism treated? Therapy, medicines and guidelines
There is no medicine for autism itself. Care aims at skills, communication, independence and the hard symptoms that come along. The American Academy of Pediatrics guideline puts early, intensive behavioral and developmental intervention first, together with education services, family support, and treatment of co-occurring conditions such as sleep problems, ADHD, anxiety and seizures [9]. Starting early helps most, but support at any age can make daily life easier.
Behavioral and developmental therapy
Applied behavior analysis and developmental approaches teach communication, play and daily-living skills in small steps, often for many hours a week in early childhood [9]. Parent training lets the same strategies continue at home.
Speech, occupational and school support
Speech-language therapy builds communication, including picture systems and devices for children who speak little. Occupational therapy works on motor skills and sensory overload. In public schools, an individualized education program (IEP) sets out services and accommodations [9].
Medicines for irritability
Risperidone and aripiprazole are FDA-approved for irritability associated with autism [2]. Their known downsides are weight gain, sedation, dizziness and nausea [3]. Other medicines target ADHD symptoms, anxiety or sleep.
Can medical cannabis help with autism?
Possibly, for some symptoms in some children — but the evidence is too thin to call it a treatment. A 2025 systematic review found 11 randomized trials of cannabis-derived products in autism, with 351 participants across the completed ones and 5 different products tested, and rated the overall evidence as inconclusive [1]. Single trials point in different directions, which is what small studies of different products usually do.
Choose a symptom to see what was tested and whether a signal showed up.
Disruptive behavior
A whole-plant cannabis extract and a mix of pure cannabinoids, both CBD-rich, against placebo in a randomized trial in children and young adults [18].
On the whole-plant extract, 49% were rated much or very much improved on disruptive behavior, a difference from placebo (p = 0.005) [18]. In a 2025 CBD-only trial, overall behavior problems did not differ from placebo (SMD 0.30, 95% CI −0.23 to 0.83) [14].
A signal in one trial, not confirmed in another. A larger trial aimed at irritability and aggression is underway [19].
Repetitive behavior
Purified CBD, raised step by step to at most 20 mg/kg a day, against placebo in a crossover trial in 39 boys with severe problem behaviors [14].
Repetitive behavior scores (RBS-R) moved slightly in CBD’s favor, but the range of likely effects included no effect at all (p = 0.095) [14].
No clear difference from placebo.
Social communication
The same whole-plant extract trial measured social responsiveness (SRS-2) [18]; the CBD-only trial used the ADOS-2 assessment [14].
SRS-2 scores improved by 14.9 points more on the whole-plant extract than on placebo (p = 0.009) [18]. In the CBD-only trial, ADOS-2 scores also improved during the placebo phase (SMD −0.70, 95% CI −1.2 to −0.21) [14].
A hint of benefit, next to a strong placebo effect.
Thinking and coordination
Oral purified CBD up to 20 mg/kg a day for 56 days in 24 boys with higher support needs, with brain-wave recordings (EEG) and skill tests [15].
Visual-motor coordination improved compared with placebo (p = 0.05), and EEG changes tracked the blood levels of CBD’s breakdown products [15][20].
An early, small finding that needs repeating.
Family life
A CBD-rich cannabis oil with a 20:1 CBD-to-THC ratio, given openly — everyone knew it was the real product — to 44 autistic children [4].
Parents reported less need to rearrange family life around the child’s needs (p = 0.001); 25.3% of families dropped out [4].
Encouraging for families, but with no placebo group the result cannot separate the product from expectations.
How big is the effect?
Smaller than the headlines suggest. A chart comparing effect sizes needs at least three trials reporting the same outcome with a margin of error; for autism, only two such numbers exist, and they answer different questions. Here they are side by side.
What this means in practice: if severe irritability or disruptive behavior has not settled with therapy and the usual medicines, a physician may consider a CBD-rich product alongside — not instead of — that care, and will weigh it against sleepiness, appetite changes and the medicines already on the list.
What the research shows, from strongest to weakest
A randomized trial in people answers “does it help?” far better than a mouse experiment or a blood test. Here is what exists for cannabinoids and autism at each level, from the summaries of many trials down to laboratory work, with background studies clearly marked.
| Level | What exists for autism | What it can and cannot tell you |
|---|---|---|
| Systematic reviews | A 2025 review of 11 randomized trials judged the evidence inconclusive [1]; another pooled 494 participants, 74.01% of them male, and found mixed results [3]; a 2024 review of CBD-rich cannabis leaned positive on low-quality data [21]. | The best overall summary; only as strong as the small trials inside it. |
| Trials in children | Placebo-controlled trials of CBD-rich extracts and purified CBD in children and teens, from 24 to 39 analyzed participants in the newest ones [18][14][15]; a trial aiming for 70 participants is underway [19]. | Can show a symptom effect and side effects; still too small and short for a firm answer. |
| Open-label and observational | Open-label and records studies of families using cannabis products [4][22]; background studies of the endocannabinoid system and of cannabis in pregnancy [8][10]. | Shows what happens in real life and what is linked to what; cannot separate the product from expectations. |
| Animal and lab work | Studies in mice, rats and zebrafish of CBD and of the receptors that THC and CBD act on [23][24][25]. | Explains why scientists are interested; says nothing yet about patients. |
Browse the studies yourself
Every study cited on this page, in plain words. Neutral and inconclusive results are included.
Cannabis-derived products for autism, all trials together
The review counted 351 participants in completed trials of 5 different cannabis products and rated the evidence as very low certainty and inconclusive [1].
Efficacy and safety of cannabinoids in autism, updated
Across the pooled studies, 74.01% of participants were male; results for behavior, sleep and anxiety were mixed, with sleepiness, appetite changes and irritability among the side effects [3].
The evolving role of CBD-rich cannabis
Clinical studies of CBD-rich cannabis reported improvements in several symptoms, but on low-quality evidence; the review flags how CBD can change the breakdown of other brain medicines [21].
Whole-plant extract vs pure cannabinoids vs placebo
Disruptive behavior improved more often on the whole-plant extract (49% much or very much improved, p = 0.005), and social responsiveness by 14.9 points (p = 0.009) [18].
Purified CBD for severe problem behaviors
No clear difference from placebo on repetitive behavior (SMD −0.44, 95% CI −0.96 to 0.07) or overall behavior; 68% of completers on CBD were correctly identified by blinded clinicians, a sign the trial was hard to keep blind [14].
CBD, brain waves and coordination
After 56 days of CBD at up to 20 mg/kg a day, EEG changes and better visual-motor scores tracked blood levels of CBD’s breakdown products [15].
The same trial, first analysis
Eight weeks of CBD; a frontal EEG measure shifted in step with CBD metabolite levels (mean difference 0.09, 95% CI 0.023 to 0.158) [20].
CBD for irritability and aggression: a trial in progress
A 27-week placebo-controlled crossover design with oral CBD started at 5 and raised to 10 mg/kg a day; results are not yet published [19].
CBD-rich cannabis and family accommodation
A 20:1 CBD-to-THC oil was followed by less family accommodation (p = 0.001), with a 25.3% dropout rate and no placebo group [4].
Safety and efficacy of cannabis in autism, in practice
A study of patients treated with medical cannabis; reviewers rated its evidence very low and its result inconclusive [22].
Lower anandamide in autistic children
Blood levels of the body’s own cannabinoid anandamide were lower in children with autism (p = 0.034) [8].
Brain activity maps and receptor maps
Differences in resting brain activity in children averaging 10.4 years of age lined up only weakly with maps of CB1 cannabinoid receptors and other receptors [26].
Cannabis before birth and later autism
No clear link between prenatal cannabis exposure and an autism diagnosis (odds ratio 0.93, 95% CI 0.55 to 1.60) [10].
Cannabis around pregnancy and autism in the child
Use around pregnancy was not associated with autism in the offspring; smoking tobacco did not change that [11].
An endocannabinoid enzyme in the cerebellum of mice
Removing the enzyme that makes the endocannabinoid 2-AG in one type of brain cell reduced social preference and raised anxiety in mice [23].
CBD vs risperidone in zebrafish
In a zebrafish model of autism-like changes, CBD and risperidone both reversed some behavioral and chemical changes in larvae [24].
Activating CB1 and CB2 receptors in rats
Drugs that switch on the two cannabinoid receptors eased autism-like behaviors and restored fat molecules in the hippocampus of rats [25].
A citrus compound working through CB1 in mice
Naringin, found in grapefruit, eased autism-like behaviors in mice through the CB1 receptor; a CB1 activator blocked the effect [27].
No studies of this type are cited on this page.
What kinds of studies is this evidence built on?
How to read it: each row is one kind of study, and the bar shows how many published studies on cannabinoids and autism are of that kind. Stronger designs are at the top. Gray bars are commentary, animal and lab work, which cannot answer whether something helps patients.
Show as a table
| Design | Studies |
|---|---|
| Meta-analyses | 1 |
| Systematic reviews | 9 |
| Randomized trials | 8 |
| Crossover randomized trials | 5 |
| Other clinical trials | 2 |
| Cohort studies | 17 |
| Case-control studies | 6 |
| Cross-sectional studies | 3 |
| Case reports | 4 |
| Narrative reviews | 32 |
| Animal studies | 12 |
| Cell and lab studies | 1 |
| Who was studied | Studies |
|---|---|
| People in clinical trials | 25 |
| People observed, not treated | 62 |
| Whole populations | 3 |
| Animals | 3 |
| Cells and molecules | 6 |
| Research methods | 1 |
| Not classified | 24 |
Which cannabinoids and doses were studied (not a prescription)
Almost every human study in autism used CBD, the cannabinoid that does not cause a high, either purified or in a plant extract with a small amount of THC. Doses were set by body weight and raised slowly over weeks while the research team watched for side effects. Those numbers describe how the studies were run; they are not a starting point for anyone at home.
| Substance | Dose used in the study | Design | What came out |
|---|---|---|---|
| Dispensary-type products (available with a medical card where your state allows) | |||
| Purified CBD, completed trials | Raised step by step to a maximum of 20 mg/kg a day, by mouth [14][15]. | Randomized crossover trials, 39 and 24 boys [14][15] | No clear difference on behavior scales; early signals on EEG and coordination [14][15]. |
| Purified CBD, trial in progress | Planned: an oral liquid of 100 mg/mL, started at 5 and raised to a target of 10 mg/kg a day [19]. | Randomized trial protocol, 27 weeks [19] | Not yet reported; this is the plan of an ongoing trial [19]. |
| CBD-rich oil, 20:1 CBD to THC | A 20:1 ratio; the dose was adjusted child by child [4]. | Open-label study, 44 children [4] | Less family accommodation (p = 0.001); a quarter of families dropped out [4]. |
| Whole-plant extract vs pure cannabinoids | Both CBD-rich, adjusted for each participant [18]. | Randomized, placebo-controlled trial | Better disruptive-behavior ratings on the whole-plant extract; more sleepiness and lower appetite on both [18]. |
| Prescription medicine (FDA-approved, by prescription, not through a card) | |||
| Epidiolex (cannabidiol) | No autism dose; dosed for epilepsy under its label. | Approved after epilepsy trials | Approved for seizures in certain rare forms of epilepsy, not for autism [28]. Its epilepsy results do not carry over to autism symptoms. |
| Dronabinol, nabilone | Not tested in the autism trials cited here. | Approved after other trials | THC-like prescription capsules approved for other uses, such as chemotherapy nausea [29]. |
CBD, THC and forms of use: what was actually studied
Cannabis is not only smoked. People also vape it, swallow it as oils, capsules or gummies, hold drops under the tongue, or put it on the skin. In the autism trials, products were oils or liquids taken by mouth or under the tongue, with far more CBD than THC [14][4]. Smoke and vapor were not studied in autism and have no place in a child’s care. This section explains what each form avoids and what it keeps; it does not recommend one.
Which form are you asking about?
Choose the closest; the card at the bottom is true of every form.
Specific to smoking
Joints, blunts, pipes and bongs burn plant material, and the smoke irritates the throat and lungs. The dose is hard to measure, and the smoke reaches anyone nearby — one reason smoking around children is a risk of its own; see the risks of smoking cannabis around children.
Specific to vaping and dabbing
Dry-herb vaporizers, oil pens and cartridges avoid burning, but hot vapor still travels the same airways. Concentrates used for dabbing, such as wax, shatter or rosin, are very strong, which makes the dose even harder to control. None of this was part of the autism research.
Shared devices
A pipe, vape or joint passed between people also passes on colds and other infections.
Specific to edibles and capsules
Gummies, chocolates, drinks, capsules and swallowed oils avoid smoke entirely. They act slowly, often an hour or more, and last for hours, because the liver processes them before they reach the blood. Two risks stand out: a second dose taken “because the first did nothing,” and gummies that look like candy to a child who finds them.
Specific to oils and tinctures
Oils and drops taken by mouth or held under the tongue are the form used in the autism trials [14][4]. They are measured by the milliliter or the drop, so a dose can be repeated exactly. Part of the dose is still swallowed and passes through the liver.
Specific to topicals and patches
Creams and balms act mainly where they are applied and are not a way to reach behavior or sleep. Transdermal patches are different: they deliver cannabinoids into the bloodstream, so their effects on the brain and on other medicines count the same as any other form.
Specific to prescription cannabinoids
Epidiolex is a pharmaceutical CBD liquid prescribed for certain seizure disorders and filled at a pharmacy, not bought with a medical card; it is not approved for autism [28]. Dronabinol and nabilone are THC-like capsules approved for other uses [29].
True of every form
- CBD and THC are processed by liver enzymes that also handle many behavior and seizure medicines [21].
- Sleepiness and lower appetite were the most common side effects in the trials [18].
- THC acts on a developing brain; the long-term effects in children are not known.
- Products must be stored locked away, and no one should drive after using THC.
Choosing a form is a conversation for the appointment.
All forms as a table
| Form | What it avoids | What remains |
|---|---|---|
| Smoking | Delay in onset | Smoke in the airways and for people nearby, shared devices, hard-to-measure dose, all effects of THC |
| Vaping & dabbing | Burning plant material | Hot vapor in the airways, very strong concentrates, shared devices, all effects of THC |
| Edibles & capsules | Smoke and vapor, shared devices | Slow, long effect, risk of a repeat dose, candy-like look, liver processing, interactions |
| Oils & tinctures | Smoke and vapor, shared devices | Effects on the brain, partly swallowed dose, liver processing, interactions |
| Topicals | Most effects on the brain | Skin reactions; no effect on behavior or sleep |
| Transdermal patches | Smoke, vapor and swallowing | Effects on the brain, interactions |
| Prescription cannabinoids | Unknown product content | Sleepiness, appetite changes, interactions; not approved for autism |
What science doesn’t know yet
The gaps are most of the story. The researchers who ran these studies list their own limits plainly, and the same ones come up again and again.
- Trials are small. The newest trials analyzed 24 and 39 boys [15][14], and the open-label family study 44 children [4]. Groups this size can miss a real effect or exaggerate a chance one.
- Almost only boys. Two recent trials enrolled only males [15][14], and in the pooled studies 74.01% of participants were male [3]. How girls and women respond is largely unknown.
- Trials are short. Most lasted weeks; whether any improvement lasts, and what years of use do, has not been studied [20][15].
- Products differ from study to study. Five different cannabis products were tested across the randomized trials [1], with different CBD-to-THC ratios and no standard dose, so a result for one cannot be moved to another.
- Other medicines blur the picture. Children could stay on psychiatric medicines during some trials, which makes the effect of CBD itself harder to see [14].
- Placebo is powerful here. Scores improved during the placebo phase too [14], and open-label studies rely on parents who know what their child takes [4].
- THC and the developing brain. The trials used little or no THC. What regular THC does to a child’s or teenager’s brain over years is not answered by any study on this page.
- Animal work stays in animals. Some key experiments used only male mice [27], and zebrafish were followed only as larvae [24]. These studies explain mechanisms, not treatment.
Side effects, drug interactions and precautions
In the trials, side effects were mostly mild and common: sleepiness, lower appetite and, less often, irritability, stomach upset and trouble sleeping [3]. Doctors in the trials raised doses slowly and watched for irritability and psychoactive effects in each child, because responses varied widely.
How often did side effects show up?
How to read it: each bar is one group of the same randomized trial — a whole-plant extract, a mix of pure cannabinoids, and placebo — and shows the share of participants who had the side effect [18]. Gray is placebo, the comparison point.
Irritability
Reported in cannabinoid studies in autism [3] — the very symptom families hope to calm. A child who gets more irritable after a dose change needs a call to the physician, not a bigger dose.
Sleep disturbances
Some children slept worse, not better [3]. Daytime sleepiness can also be mistaken for calm while learning and play drop off.
Stomach and bowel symptoms
Nausea, loose stools and stomach discomfort appear in the safety reports [3], on top of the digestive problems many autistic children already have.
Psychoactive effects
A high, anxiety or odd behavior can come from THC, even in CBD-rich products [3]. Doses in the trials were adjusted child by child for this reason.
Liver and blood levels
One trial excluded children with liver disease [14], and researchers suggest checking blood levels because they varied so much between children [15].
When to call the same day
Hard-to-wake sleepiness, refusing food or drink, a new seizure, confusion, vomiting, or behavior that is suddenly much worse.
Drug interactions to discuss with a doctor
Many autistic children and adults already take one or more medicines. Open each group to see what the studies recorded and what to ask; this is not a complete list.
Antipsychotics and antidepressants (risperidone, aripiprazole, SSRIs) clinical data
What is known: taken together with cannabinoids, these medicines may add up to more sedation and other side effects [3].
What to ask the physician: Should the dose of the current medicine stay the same? How will we tell new sleepiness from the old medicine’s effect? Who adjusts what if both are used?
Behavior medicines: α2-agonists, antipsychotics, mood stabilizers, SSRIs, stimulants blood-level data
What is known: in the 2025 CBD trial, children on medicines that affect behavior — clonidine- or guanfacine-type α2-agonists, antipsychotics, mood stabilizers, SSRIs and stimulants — had lower CBD blood levels and a smaller change on the ADOS-2 assessment [14].
What to ask the physician: Could my child’s current medicines make CBD less effective? Is a blood level worth checking? Which medicine was started most recently, and could it explain a change?
Anti-seizure and other brain medicines (valproate, other antiepileptics) blood-level data
What is known: CBD and THC are broken down by the CYP450 liver enzymes that also clear many antiepileptics and antipsychotics, so levels of either can change [21]. One trial excluded children with epilepsy altogether [14], and the trial in progress excludes seizure medicines that change how CBD is processed [19].
What to ask the physician: Does my neurologist need to know before we start? Should seizure-medicine levels or liver tests be checked? What would a warning sign look like?
Bring the complete list — prescriptions, over-the-counter sleep aids, melatonin, supplements and anything given “only sometimes” — to the appointment. That list, more than the diagnosis, decides whether a cannabinoid is reasonable to try. For pain relievers taken now and then, see mixing cannabis and ibuprofen.
Have every medicine and dose written down before you start the evaluation.
Who should not use cannabis for autism symptoms
For some people the answer is “not now” or “not at all,” whatever the symptom. Trials in autism exclude these groups, so there is no evidence of safety for them.
- A personal history of psychosis — hallucinations or delusions; THC can bring them back or worsen them. See cannabis and psychosis.
- Epilepsy treated with medicines that interact with CBD, and tuberous sclerosis — excluded from a recent CBD trial [14]; seizure care comes first, through the neurologist.
- Liver disease — also an exclusion in that trial, because the liver handles both CBD and many of the other medicines [14].
- Pregnancy or breastfeeding — THC reaches the baby, and safety is not established.
- A new, unexplained change in behavior — pain, illness, a medicine side effect or a crisis needs checking first.
Talk to a licensed physician about whether any of these apply
Does autism qualify for a medical marijuana card?
It depends on your state. Every medical cannabis program keeps its own list of qualifying conditions, and a physician has to match a diagnosis in your records to that list, not a symptom. Some programs name autism outright. Others do not, but cover conditions that often come with it — seizures, anxiety, insomnia — and some let a physician certify any condition they judge debilitating.
The lists change as legislatures and health departments update them, so the current wording in your state is the one that counts. Rules for patients under 18 are set separately, usually with a parent or guardian registered alongside. The physician confirms all of this at the evaluation, using your records.
Autism is named in your state
The simplest case. Bring the diagnosis record — a developmental pediatrician’s, neurologist’s or psychologist’s report — and the physician evaluates you or your child against that listed condition.
A condition you also have is listed
Epilepsy, anxiety, PTSD or insomnia may be on the list even where autism is not. What counts is a diagnosis in the records, not a symptom alone.
Neither is on the list
A card may not be available yet where you live. Some states let physicians certify other debilitating conditions or accept petitions to add new ones.
What else has a doctor diagnosed?
State lists name diagnoses, not symptoms — pick what is in the records.
Anxiety: several states list anxiety disorders or accept them under broader wording, and anxiety is common alongside autism. Read anxiety and medical cannabis.
PTSD: one of the most widely listed mental health conditions. Bullying and other trauma can lead to it in autistic children and adults. Read PTSD and medical cannabis.
Insomnia: a diagnosed sleep disorder is listed in some programs and is often recorded alongside autism. Read insomnia and medical cannabis.
Epilepsy or seizures: seizure disorders are on most lists; mind the anti-seizure interactions above. Read epilepsy and medical cannabis and seizures and medical cannabis.
Depression: fewer states list it, and THC can affect mood in both directions. Read depression and medical cannabis.
None of these: then the decision rests on your state’s wording and the physician’s judgment. Start with your state’s medical marijuana laws.
Medical card, recreational purchase or hemp CBD from a shop
Three ways to get a cannabinoid product, three very different levels of oversight. For a child, only one of them is open at all.
| Aspect | Medical card | Recreational | Hemp CBD products |
|---|---|---|---|
| Age | Minors can take part only through a medical program, with a parent or guardian | Adults 21 and older only | Age rules vary by state and store |
| Product testing | Lab-tested and labeled with THC and CBD content in licensed dispensaries | Lab-tested under state adult-use rules | Testing and labeling are looser; content may not match the label |
| Taxes and limits | Often lower taxes and higher purchase limits, set by each state | Full cannabis taxes; adult-use limits | Ordinary retail; no medical limits |
| Physician involvement | A licensed physician reviews diagnoses and medicines | None | None |
| Advice at purchase | Dispensary staff, and a pharmacist in some states | Sales staff | Usually none |
Will a card save you money?
It can, but only where your state taxes patients less than recreational buyers, and the amount depends on your state’s tax rates and how much is bought. Weigh that against the evaluation fee and any state registration fee. The breakdown is in medical vs. recreational cannabis taxes, and the wider differences in medical and recreational cannabis compared. To check eligibility first, use the questions above.
What the program in your state involves
Qualifying is the first of two steps. In most states a physician’s recommendation is followed by registration with the state health department, which issues the card and enters the patient in a confidential registry; in a few, the recommendation itself is what a dispensary asks for. Purchases happen at licensed dispensaries, some of which deliver.
Dispensary products come with a certificate of analysis (COA): a lab report for that batch. Read three lines on it — the CBD and THC amounts per milliliter or per piece, which tell you the ratio; the date of the test; and the screens for contaminants such as pesticides, solvents and heavy metals. If a product has no COA, that is an answer in itself.
Many state laws also let a patient — or the parent of a minor patient — name a registered caregiver who may buy and handle products on their behalf; who qualifies and how to register is set by each state. Cards from one state are not automatically valid in another — see which states accept out-of-state cards. Possession limits, home growing and taxes are listed state by state on the laws and regulations pages.
Which situation is yours?
Pick the closest; each answer ends with where to go next.
Parent of an autistic child: you make this decision for your child, and your state decides whether a minor can be certified and how a parent registers. Start by talking with the pediatrician or neurologist who knows your child best, and bring the list in the next section.
Autistic adult: you apply for yourself. Have your diagnosis record and your medicine list ready; if autism is not on your state’s list, a co-occurring diagnosis such as anxiety or insomnia may be. Everything happens online and in writing.
Renewing a card: cards expire on a schedule your state sets, and renewal means a repeat evaluation. Note any change in diagnosis, medicines or dose since last time — for a growing child, weight changes too.
Moving to another state: a card belongs to the state that issued it. In the new state you usually apply again under its rules, and its list of qualifying conditions may differ.
For parents of autistic children
If you are reading this for your child, you are the one who weighs it, and you do not have to decide today. A minor cannot apply alone: where a state allows medical cannabis for patients under 18, a parent or legal guardian is part of the application, often registered alongside the child, and many states ask for more than one physician’s sign-off. The rules are set state by state; the basics are in medical marijuana and minors and the legal age for CBD.
The best first conversation is with the pediatrician, developmental pediatrician or neurologist who already knows your child. They know the seizure history, the medicines and the growth chart, and they can tell you whether a cannabinoid fits alongside what is already working.
What to bring to the pediatrician or neurologist
Tap each item as you get it ready.
At school and at home
At home, a cannabinoid product is a medicine: locked away, given by one named adult, and written down with the time and the amount. At school, the rules come from state law and the district. A few states let a parent or school nurse give a medical cannabis product on school grounds under set conditions; many do not allow it at all, and products are not kept in a backpack. Ask the school in writing before anything changes, and tell the teacher what side effects to watch for, such as sleepiness after lunch.
What this means if you are considering it
A good evaluation is a conversation about one or two specific symptoms, the medicines already in use and what would count as “better.” It goes faster and safer when the facts are on the table.
Questions worth asking
- Which of the current medicines could interact, and what would we watch for?
- CBD alone or with a little THC — and why that choice for this symptom?
- How would we know within a few weeks whether it is helping?
- What should make us stop right away?
- Who do we call if sleepiness, appetite or behavior gets worse?
An evaluation makes sense if
- A specific symptom — irritability, aggression, sleep, anxiety — has not settled with therapy and the usual medicines.
- The full medicine list can be reviewed.
- Someone can keep track of doses and changes.
- Your state’s program covers autism or a co-occurring diagnosis.
It is not the right step if
- The hope is to cure or remove autism.
- A behavior change is new and has not been checked.
- Seizures are not yet under a neurologist’s care.
- There is a history of psychosis.
A safety plan for hard days
Autistic children and adults live with higher rates of anxiety, depression and bullying, and some face thoughts of suicide [2]. A written plan, made on a calm day, makes a crisis day easier. Keep it where everyone who helps can find it.
- Know the warning signs. Talk of not wanting to live, giving things away, a sudden drop in eating or sleeping, new self-injury, or a calm that follows weeks of distress. In an autistic person, signs may show as behavior rather than words.
- Know the signs of psychosis. Hearing or seeing things others do not, fixed false beliefs, or speech that stops making sense. THC can trigger or worsen psychosis, so stop any THC product and call the physician the same day.
- Make the space safer. Lock away medicines, cannabis products, sharp objects and firearms.
- Calm steps that work for this person. A quiet room, noise-canceling headphones, a weighted blanket, a familiar video — write down what helps.
- Who to call. Call or text 988, the Suicide & Crisis Lifeline, any time [30]; call 911 if someone is in immediate danger. For abuse at home, the National Domestic Violence Hotline is 1-800-799-7233 [31].
- If bullying is part of it. Write down what happened and when, tell the school in writing, and ask for a meeting about the IEP or 504 plan. Bullying that does not stop can lead to anxiety, depression and PTSD; see a mental health professional if sleep, school or mood change for more than two weeks.
This page summarizes published research for education. It does not replace a physician’s advice. Cannabis does not treat autism itself, the trials in children are small, and the product, dose and form are chosen by a physician.
How to get a medical marijuana card for autism: step by step
Everything happens online, so there is nowhere to travel and no waiting room to sit in. Four steps take you from the first form to a card.
Fill in the intake form
Your state, the diagnoses and the current medicines. Have the autism diagnosis record and any co-occurring diagnoses ready to upload.
See a physician licensed in your state
A one-on-one appointment online. You agree on the time with the physician; keep an hour free rather than a minute.
Receive your signed recommendation
If the physician approves, the signed recommendation arrives in your account after the appointment.
Register with your state
Where required, you submit the recommendation to the state program, which reviews it and issues the card.
What you end up with
Across 250 reviews from patients in the states where we are licensed. We do not sort them by score and do not hide the low ones.
- 150,000+patients evaluated — everyone who has been through an appointment with us, in every state where we are licensed
- Since 2017doing only this: online evaluations for medical cannabis programs, and nothing else on the side
A recommendation from a physician licensed where you live, and — once your state registers it — a card that lets you buy at licensed dispensaries. Your documents stay in your account and documents, and how the medical card works explains the evaluation in detail. Programs for veterans and for people with low income are available in some states.
Who sees you and who reviews this page
The appointment is with a physician who holds an active license in your state and sees you one-on-one; the physicians are listed on our physicians page. This page was written from the studies in the reference list below and medically reviewed by the same team, and the date of the last review is shown under the first screen. Your medical information is protected under the HIPAA Privacy Rule [32].
What it costs and what is included
The evaluation fee for your state is shown before you pay, and it covers the intake review, the appointment and the signed recommendation if the physician approves. A state registration fee, where one exists, is paid to the state separately. Whether a recommendation is issued is the physician’s medical decision; what happens if you are not approved is set out on how the medical card works.
Autism spectrum disorder and cannabis: questions people ask
Is “autism spectrum disorder” capitalized?
No. It is the name of a condition, not a proper noun, so it is written in lowercase in running text: “a diagnosis of autism spectrum disorder.” The abbreviation is written in capitals, ASD, and the word is capitalized only at the start of a sentence or in a title.
Can a child get a medical marijuana card for autism?
In some states, yes. The state has to allow patients under 18, autism or a co-occurring condition has to be on its list, and a parent or legal guardian takes part in the application. Some states ask for two physicians. Recreational purchase is closed to anyone under 21. Start with medical marijuana and minors and your state on the laws and regulations pages.
Does Epidiolex help autism?
Epidiolex is a prescription CBD medicine approved by the FDA for seizures in certain rare forms of epilepsy; it is not approved for autism [28]. If an autistic child also has one of those epilepsies, a neurologist may prescribe it for the seizures. For autism symptoms themselves, the purified-CBD trials so far show no clear difference from placebo on behavior scales [14].
Is CBD from shops or online the same? What about delta-8?
Not necessarily. Hemp-derived CBD sold in shops and online is less tightly regulated than dispensary products, and the label may not match what is inside — including THC that is not listed. Delta-8 THC acts much like regular THC, with the same sleepiness, anxiety and interaction risks, and it is not a CBD product at all. The trials on this page used pharmaceutical-grade or tested products with known content.
What autism spectrum disorder benefits can a family get?
Autistic children from families with limited income and resources may qualify for Supplemental Security Income (SSI) if their condition meets Social Security’s criteria for autism spectrum disorder [33]; adults can apply on their own records. Medicaid, state autism insurance rules and school services under an IEP can cover therapies. National groups such as the Autism Society of America and the Autism Science Foundation keep lists of local support and research news.
Is medical cannabis allowed for autism in Hong Kong?
No. Hong Kong treats cannabis as a dangerous drug, and CBD has also been a controlled dangerous drug there since February 1, 2023 [34]. A U.S. medical card is valid only under the law of the state that issued it and gives no rights in Hong Kong or anywhere outside the United States. Families in Hong Kong should discuss autism treatment with a local doctor.
Is an online evaluation legitimate?
Yes, where state law allows telemedicine for medical cannabis evaluations. The appointment is with a physician licensed in your state, one-on-one, and the recommendation is the same document an in-person visit would produce. For a child, the parent or guardian joins the appointment.
Can I use my card in another state?
Sometimes. Reciprocity — one state honoring another state’s card — exists in some states and not others, and rules for visitors vary. Check which states accept out-of-state cards and traveling with cannabis before a trip. Flying with cannabis across state lines is not allowed under federal law.
How do I renew a medical card for autism?
Cards expire on a schedule your state sets, often after one year, and renewal means a repeat evaluation with updated medicines and a new recommendation. Start a few weeks before the expiry date so there is no gap. For a child, the physician recertifies the minor patient and the parent or guardian renews alongside; bring the current weight, any new diagnosis and every medicine change since last time. See how the medical card works or the medical card FAQ.
What if my card is lost?
Most states let you request a replacement from the program that issued it. The steps are in what to do if your card is lost and the medical card FAQ.
How much does it cost, and what if I’m not approved?
The evaluation fee for your state is shown before you pay; a state registration fee, where one exists, is paid to the state separately. Whether a recommendation is issued is the physician’s medical decision. Details for both are on how the medical card works.
Who finds out? Privacy, firearms, work and school
Privacy: your medical records are protected under the HIPAA Privacy Rule [32], and state patient registries are confidential; dispensaries and law enforcement can usually check only whether a card is valid.
Firearms: federal law bars anyone who is an “unlawful user” of a controlled substance from having a firearm [35], and cannabis remains federally controlled, so a state card does not change the federal rule. The federal purchase form, ATF Form 4473, asks this question directly.
Work: employment protections for card holders differ by state, and many employers can still enforce drug-free policies, especially in safety-sensitive jobs.
School and custody: school rules follow state law and district policy, and most schools do not allow cannabis products on site without a written arrangement. In family-court disputes, a child’s cannabis treatment or a parent’s card can come up; what counts is state law, so ask a family-law attorney before it becomes a question. State rules are on the laws and regulations pages.
Related brain and nervous system conditions
Autism often travels with other diagnoses, and several of them appear on more state lists than autism does. Each page below covers its own research and qualifying rules.
Autism resources and latest research
For background on how cannabis works in the body, and for new articles as research and laws change:
References
35 sources
- 1. Therapeutic Use of Cannabis Derivatives and Their Analogs for Autism Spectrum Disorder: A Systematic Review. DOI: 10.1002/jcph.70068 PMID: 40605143
- 2. National Institute of Mental Health. Autism Spectrum Disorder. 2024.
- 3. Efficacy and Safety of Cannabinoids for Autism Spectrum Disorder: An Updated Systematic Review. DOI: 10.7759/cureus.80725 PMID: 40248548
- 4. Effects of Medical Cannabis Treatment for Autistic Children on Family Accommodation: An Open-Label Mixed-Methods Study. DOI: 10.3390/children12101373 PMID: 41153555
- 5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). 2022.
- 6. Centers for Disease Control and Prevention. Clinical Testing and Diagnosis for Autism Spectrum Disorder. 2024.
- 7. Centers for Disease Control and Prevention. Data and Statistics on Autism Spectrum Disorder. 2025.
- 8. Plasma anandamide concentrations are lower in children with autism spectrum disorder. DOI: 10.1186/s13229-018-0203-y PMID: 29564080
- 9. American Academy of Pediatrics. Identification, Evaluation, and Management of Children With Autism Spectrum Disorder. 2020.
- 10. Examining the association between prenatal cannabis exposure and child autism traits: A multi-cohort investigation in the environmental influences on child health outcome program. DOI: 10.1002/aur.3185 PMID: 38953698
- 11. Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development. DOI: 10.1007/s10803-021-05339-4 PMID: 34767135
- 12. National Center for Health Statistics, CDC. International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). 2025.
- 13. World Health Organization. International Classification of Diseases, 11th Revision (ICD-11). 2024.
- 14. Cannabidiol (CBD) Treatment for Severe Problem Behaviors in Autistic Boys: A Randomized Clinical Trial. DOI: 10.1007/s10803-025-06884-y PMID: 40410546
- 15. Cannabidiol blood metabolite levels after cannabidiol treatment are associated with broadband EEG changes and improvements in visuomotor and non-verbal cognitive abilities in boys with autism requiring higher levels of support. DOI: 10.1038/s41398-026-03815-y PMID: 41611664
- 16. Centers for Disease Control and Prevention. About Attention-Deficit/Hyperactivity Disorder (ADHD). 2024.
- 17. Centers for Disease Control and Prevention. About Fetal Alcohol Spectrum Disorders (FASDs). 2024.
- 18. Cannabinoid treatment for autism: a proof-of-concept randomized trial. DOI: 10.1186/s13229-021-00420-2 PMID: 33536055
- 19. Cannabidiol for treatment of irritability and aggressive behavior in children and adolescents with autism spectrum disorder: background and methods of the cannabidiol study in children with autism spectrum disorder study. DOI: 10.18203/2349-3259.ijct20250131 PMID: 41103807
- 20. Cannabidiol blood metabolite levels after cannabidiol treatment are associated with broadband EEG changes and improvements in visuomotor and non-verbal cognitive abilities in boys with autism requiring higher levels of support. DOI: 10.1101/2024.09.27.24314448 PMID: 41378349
- 21. The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review. DOI: 10.3390/ijms252212453 PMID: 39596518
- 22. Safety and Efficacy of Cannabis in Autism Spectrum Disorder. DOI: 10.15844/pedneurbriefs-34-25 PMID: 33376294
- 23. Deletion of Endocannabinoid Synthesizing Enzyme DAGLα in Pcp2-Positive Cerebellar Purkinje Cells Decreases Depolarization-Induced Short-Term Synaptic Plasticity, Reduces Social Preference, and Heightens Anxiety. DOI: 10.1523/ENEURO.0400-24.2025 PMID: 40523777
- 24. Comparative Analysis of Cannabidiol and Risperidone on Behavioral and Neurochemical Outcomes, and Neurodevelopment Markers in a Zebrafish Model of Embryonic Exposure to Sodium Valproate. DOI: 10.1002/aur.70151 PMID: 41293963
- 25. Cannabinoid Receptors CB1 and CB2 Activation Restores Hippocampal Lipid Profiles and Alleviates Autism-Like Behaviors in Valproic Acid-Induced ASD Rats. DOI: 10.1111/cns.70591 PMID: 40852923
- 26. Mapping Resting-State Brain Functional Specialization to Neurotransmitter Profiles in Autism Spectrum Disorder. DOI: 10.1111/cns.70666 PMID: 41277752
- 27. Naringin Alleviates Autistic-Like Behaviors in BTBR Mice Through Cannabinoid Receptor Type 1-Mediated Restoration of Hippocampal Neurogenesis. DOI: 10.1111/cns.70654 PMID: 41315878
- 28. U.S. Food and Drug Administration. FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy. 2018.
- 29. U.S. Food and Drug Administration. FDA and Cannabis: Research and Drug Approval Process. 2023.
- 30. 988 Suicide & Crisis Lifeline. 988 Suicide & Crisis Lifeline. 2024.
- 31. National Domestic Violence Hotline. National Domestic Violence Hotline. 2024.
- 32. U.S. Department of Health and Human Services. The HIPAA Privacy Rule. 2024.
- 33. Social Security Administration. 112.00 Mental Disorders — Childhood. 2024.
- 34. Narcotics Division, Security Bureau, Hong Kong SAR Government. Narcotics Division. 2023.
- 35. Legal Information Institute, Cornell Law School. 18 U.S. Code § 922 — Unlawful acts. 2024.